Health Care [ 4/12 ] | Health Care Technology [ 70/72 ]
NASDAQ | Common Stock
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers (HCPs), and patients.
Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow.
The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution, which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems.
In addition, it provides Patient Engagement, a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow, a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs.
The company was founded in 2006 and is headquartered in Rochester, Michigan.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 20, 24 | 0.26 Increased by +388.89% | -0.13 Increased by +300.00% |
| Mar 28, 24 | 0.26 Increased by +4.00% | 0.32 Decreased by -18.75% |
| Nov 6, 23 | 0.09 Increased by +28.57% | 0.03 Increased by +200.00% |
| Aug 14, 23 | -0.01 Decreased by -125.00% | -0.02 Increased by +50.00% |
| May 10, 23 | -0.09 Decreased by -800.00% | -0.08 Decreased by -12.50% |
| Mar 8, 23 | 0.25 Increased by +13.64% | 0.24 Increased by +4.17% |
| Nov 8, 22 | 0.07 Decreased by -22.22% | 0.04 Increased by +75.00% |
| Aug 9, 22 | 0.04 Decreased by -60.00% | 0.09 Decreased by -55.56% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 23 | 16.33 M Increased by +8.26% | -2.87 M Increased by +9.81% | Decreased by -17.54% Increased by +16.69% |
| Jun 30, 23 | 13.82 M Decreased by -1.15% | -4.16 M Decreased by -7.78% | Decreased by -30.12% Decreased by -9.04% |
| Mar 31, 23 | 13.00 M Decreased by -5.31% | 659.07 M Increased by +17.62 K% | Increased by +5.07 K% Increased by +18.61 K% |
| Dec 31, 22 | 19.65 M Decreased by -3.24% | 212.68 K Decreased by -65.89% | Increased by +1.08% Decreased by -64.75% |
| Sep 30, 22 | 15.09 M Decreased by -6.45% | -3.18 M Decreased by -8.06 K% | Decreased by -21.06% Decreased by -8.61 K% |
| Jun 30, 22 | 13.98 M Increased by +2.59% | -3.86 M Decreased by -1.20 K% | Decreased by -27.62% Decreased by -1.17 K% |
| Mar 31, 22 | 13.73 M Increased by +22.28% | -3.76 M Decreased by -490.09% | Decreased by -27.39% Decreased by -382.56% |
| Dec 31, 21 | 20.31 M Increased by +23.66% | 623.46 K Decreased by -54.06% | Increased by +3.07% Decreased by -62.85% |